Eli Lilly 2013 Annual Report Download - page 8
Download and view the complete annual report
Please find page 8 of the 2013 Eli Lilly annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1 -
2 -
3 -
4 -
5 -
6 -
7 -
8 -
9 -
10 -
11 -
12 -
13 -
14 -
15 -
16 -
17 -
18 -
19 -
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
-
60
-
61
-
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110
-
111
-
112
-
113
-
114
-
115
-
116
-
117
-
118
-
119
-
120
-
121
-
122
-
123
-
124
-
125
-
126
-
127
-
128
-
129
-
130
-
131
-
132
-
133
-
134
-
135
-
136
-
137
-
138
-
139
-
140
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
-
159
-
160
 |
 |
6
Eli Lilly and Company was founded more than a century ago by a man committed to creating high-quality
medicines based on the best science of the day, and today we remain true to that mission in all our work.
In recent years, while other pharmaceutical companies were cutting R&D, Lilly stuck to our innovation-based
strategy. Despite the nancial pressures during the YZ period of patent expiries on a number of major products,
we sustained investment in R&D and—as a result of that determined eort—we successfully rebuilt our late-stage
pipeline of potential new medicines.
is is our heritage: the world’s rst commercially available insulin product...the rst mass production of penicillin
and, later, of the polio vaccine…important new classes of antibiotics in the 1950s through 1980s…Humulin®, the
world’s rst human health care product created using recombinant DNA technology
…Prozac®, which revolutionized the treatment of depression…further advances
in neuroscience—Zyprexa® and Cymbalta®, both among only 20 medicines
ever to reach $5 billion in annual sales…new treatments for cancer, from
Velban® in the 1960s, to Gemzar® in the 1990s, to Alimta® in the 2000s
…and more—making life better for people around the world.
On the following pages, we highlight how the determined eorts of
Lilly people have led to advances against two devastating diseases—
diabetes and cancer—and how we’re building on this legacy of
discovery as we prepare to launch potential new medicines in these
key therapeutic areas over the coming year.
Determination Leads to Discovery